Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126033851 | 12603385 | 1 | I | 201503 | 20151106 | 20160728 | 20160728 | EXP | US-PFIZER INC-2015385749 | PFIZER | 65.00 | YR | M | Y | 0.00000 | 20160728 | LW | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126033851 | 12603385 | 1 | PS | TESTOSTERONE CIPIONATE | TESTOSTERONE | 1 | UNK, MONTHLY | U | 85635 | /month | |||||||||
| 126033851 | 12603385 | 2 | SS | TESTOSTERONE CIPIONATE | TESTOSTERONE | 1 | 200 MG, UNK (1 CC) | U | 85635 | 200 | MG | SOLUTION FOR INJECTION | |||||||
| 126033851 | 12603385 | 3 | SS | ANDROGEL | TESTOSTERONE | 1 | UNK, PUMP DAILY | U | 0 | ||||||||||
| 126033851 | 12603385 | 4 | SS | ANDROGEL | TESTOSTERONE | 1 | UNK, DAILY | U | 0 | ||||||||||
| 126033851 | 12603385 | 5 | SS | TESTIM | TESTOSTERONE | 1 | 1 %, DAILY | U | 0 | 1 | PCT | GEL | |||||||
| 126033851 | 12603385 | 6 | SS | TESTIM | TESTOSTERONE | 1 | 1 %, DAILY | U | 0 | 1 | PCT | GEL | |||||||
| 126033851 | 12603385 | 7 | SS | TESTIM | TESTOSTERONE | 1 | 1 %, DAILY | U | 0 | 1 | PCT | GEL | |||||||
| 126033851 | 12603385 | 8 | SS | TESTIM | TESTOSTERONE | 1 | 1 %, DAILY | U | 0 | 1 | PCT | GEL | |||||||
| 126033851 | 12603385 | 9 | SS | TESTOPEL | TESTOSTERONE | 1 | 750 MG, UNK (PELLETS IMPLANT) | U | 0 | 750 | MG | ||||||||
| 126033851 | 12603385 | 10 | SS | TESTOPEL | TESTOSTERONE | 1 | 750 MG, UNK (PELLETS IMPLANT) | U | 0 | 750 | MG | ||||||||
| 126033851 | 12603385 | 11 | SS | TESTOPEL | TESTOSTERONE | 1 | 750 MG, UNK (PELLETS IMPLANT) | U | 0 | 750 | MG | ||||||||
| 126033851 | 12603385 | 12 | SS | TESTOPEL | TESTOSTERONE | 1 | 900 MG, UNK (PELLETS IMPLANT) | U | 0 | 900 | MG | ||||||||
| 126033851 | 12603385 | 13 | SS | TESTOPEL | TESTOSTERONE | 1 | 900 MG, UNK (PELLETS IMPLANT) | U | 0 | 900 | MG | ||||||||
| 126033851 | 12603385 | 14 | SS | TESTOPEL | TESTOSTERONE | 1 | 900 MG, UNK (PELLETS IMPLANT) | U | 0 | 900 | MG | ||||||||
| 126033851 | 12603385 | 15 | SS | TESTOPEL | TESTOSTERONE | 1 | 900 MG, UNK (PELLETS IMPLANT) | U | 0 | 900 | MG | ||||||||
| 126033851 | 12603385 | 16 | SS | ANDRODERM | TESTOSTERONE | 1 | UNK | U | 0 | ||||||||||
| 126033851 | 12603385 | 17 | SS | ANDRODERM | TESTOSTERONE | 1 | UNK | U | 0 | ||||||||||
| 126033851 | 12603385 | 18 | SS | ANDRODERM | TESTOSTERONE | 1 | UNK | U | 0 | ||||||||||
| 126033851 | 12603385 | 19 | SS | AXIRON | TESTOSTERONE | 1 | UNK, DAILY | U | 0 | ||||||||||
| 126033851 | 12603385 | 20 | SS | AXIRON | TESTOSTERONE | 1 | UNK, DAILY | U | 0 | ||||||||||
| 126033851 | 12603385 | 21 | SS | AXIRON | TESTOSTERONE | 1 | UNK, DAILY | U | 0 | ||||||||||
| 126033851 | 12603385 | 22 | SS | AXIRON | TESTOSTERONE | 1 | UNK, DAILY | U | 0 | ||||||||||
| 126033851 | 12603385 | 23 | SS | TESTOSTERONE. | TESTOSTERONE | 1 | 200 MG, UNK | U | 0 | 200 | MG | INJECTION | |||||||
| 126033851 | 12603385 | 24 | SS | TESTOSTERONE. | TESTOSTERONE | 1 | UNK | U | 0 | INJECTION |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126033851 | 12603385 | 1 | Hormone replacement therapy |
| 126033851 | 12603385 | 2 | Hormone replacement therapy |
| 126033851 | 12603385 | 3 | Hormone replacement therapy |
| 126033851 | 12603385 | 5 | Hormone replacement therapy |
| 126033851 | 12603385 | 9 | Hormone replacement therapy |
| 126033851 | 12603385 | 16 | Hormone replacement therapy |
| 126033851 | 12603385 | 19 | Hormone replacement therapy |
| 126033851 | 12603385 | 23 | Hormone replacement therapy |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126033851 | 12603385 | HO |
| 126033851 | 12603385 | OT |
| 126033851 | 12603385 | DS |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126033851 | 12603385 | Aneurysm | |
| 126033851 | 12603385 | Cerebrovascular accident | |
| 126033851 | 12603385 | Disability | |
| 126033851 | 12603385 | Fatigue | |
| 126033851 | 12603385 | Impaired work ability | |
| 126033851 | 12603385 | Memory impairment |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126033851 | 12603385 | 1 | 20080418 | 20081004 | 0 | |
| 126033851 | 12603385 | 2 | 20141117 | 0 | ||
| 126033851 | 12603385 | 3 | 20120711 | 0 | ||
| 126033851 | 12603385 | 4 | 20120822 | 20121209 | 0 | |
| 126033851 | 12603385 | 5 | 20081216 | 20091221 | 0 | |
| 126033851 | 12603385 | 6 | 20100125 | 20100729 | 0 | |
| 126033851 | 12603385 | 7 | 20100310 | 0 | ||
| 126033851 | 12603385 | 8 | 20100830 | 20101123 | 0 | |
| 126033851 | 12603385 | 9 | 20120202 | 0 | ||
| 126033851 | 12603385 | 10 | 20130308 | 0 | ||
| 126033851 | 12603385 | 11 | 20140123 | 0 | ||
| 126033851 | 12603385 | 12 | 20130827 | 0 | ||
| 126033851 | 12603385 | 13 | 20140624 | 0 | ||
| 126033851 | 12603385 | 14 | 20141201 | 0 | ||
| 126033851 | 12603385 | 15 | 20140905 | 0 | ||
| 126033851 | 12603385 | 16 | 20120526 | 0 | ||
| 126033851 | 12603385 | 17 | 20120530 | 0 | ||
| 126033851 | 12603385 | 18 | 20120605 | 0 | ||
| 126033851 | 12603385 | 19 | 20120525 | 20120807 | 0 | |
| 126033851 | 12603385 | 20 | 20121126 | 0 | ||
| 126033851 | 12603385 | 21 | 20121206 | 0 | ||
| 126033851 | 12603385 | 22 | 20130201 | 0 | ||
| 126033851 | 12603385 | 23 | 20140623 | 0 | ||
| 126033851 | 12603385 | 24 | 20140821 | 0 |